✦ LIBER ✦

Lack of antibodies to LAV /HTLV-III in hepatitis B vaccine recipients

✍ Scribed by G. Papaevangelou; A. Roumeliotou-Karayannis; G. Kallinikos; K. Politou

Publisher: Springer
Year: 1985
Tongue: English
Weight: 247 KB
Volume: 1
Category: Article
ISSN: 0393-2990
DOI: 10.1007/bf00237110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccination of 113 hemophili

Hepatitis B vaccination of 113 hemophiliacs: Lower antibody response in anti-LAV/HTLV-III-positive patients

✍ A. R. Zanetti; P. M. Mannucci; E. Tanzi; G. A. Moroni; M. De Paschale; M. Morfin 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

One-hundred thirteen adults and children with hemophilia or other congenital bleeding disorders were vaccinated against the hepatitis B virus. Each patient was given three subcutaneous injections of the vaccine at monthly intervals and then a fourth booster dose 14 months after the first. The vaccin

Failure to detect LAV/HTLV-III antibodie

Failure to detect LAV/HTLV-III antibodies in Southeastern Zaire

✍ G. Harms; K. Zwingenberger; H. Feldmeier; U. Bienzle; B. Zorr 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Lack of immune potentiation by complexin

Lack of immune potentiation by complexing HBsAg in a heat-inactivated hepatitis B Vaccine with antibody in hepatitis B immunoglobulin

✍ Dr. P. Nico Lelie; Peter J. A. J. van Amelsfoort; C. S. Martine de Groot; Ed Bak 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 1 views

In a randomized, dose-response study among 305 health care workers, we examined whether the immunogenicity of a heat-inactivated hepatitis B vaccine could be enhanced when HBsAg was complexed by anti-HBs contained in hepatitis B immunoglobulin either at equivalent proportions or at 10-fold antigen e

In Vitro Response to HBsAg of Peripheral

In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine

✍ Tse Wen Chang; Esteban Celis; Richard W. Miller; Vincent R. Zurawski Jr.; Patric 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

Lymphocytes isolated from recipients of hepatitis B vaccine were studied for their immune response to HBsAg in uitro. Peripheral blood mononuclear cells (PBMs) from 70 to 80% of 40 vaccinees yielded proliferative indices larger than 2 after 5 to 7 days incubation with HBsAg. This in uitro proliferat

Diminished responsiveness of male homose

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferon

✍ J. A. McDonald; L. Caruso; P. Karayiannis; L. J. Scully; J. R. W. Harris; G. E. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

In a randomized controlled trial, 41 chronic hepatitis B virus carriers were allocated, by opening numbered computerized randomization envelopes, to receive recombinant interferon-a2A at three different doses: 2.5; 5.0, and 10.0 mU per m2. Thirty-two patients received treatment (6 for 3 months, 26 f

Escape hepatitis B virus mutations in re

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen–positive liver grafts receiving hepatitis B immunoglobulins

✍ Bruno Roche; Anne-Marie Roque-Afonso; Mylene Sebagh; Valerie Delvart; Jean Charl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

A variety of prophylactic strategies are used to prevent the risk of hepatitis B virus (HBV) transmission from antibody to hepatitis B core antigen (anti-HBc)-positive donors. The mechanisms underlying the failure of HBV immunoglobulin monoprophylaxis have been poorly evaluated. Seventy-seven anti-H